Skip to main content
May 27, 2022
Understanding Back Pain
Rheumatologic Disorders
Mechanical Disorders
Newsletter
Join the Community
Understanding Back Pain
Rheumatologic Disorders
Mechanical Disorders
Newsletter
Join the Community
Oral Therapy
Rheumatologic Disorders
Xeljanz (tofacitinib) First Oral Therapy Approved for Ankylosing spondylitis (AS)
By Dr. David Borenstein
Jan 17, 2022
CLOSE
CLOSE
CLOSE
CLOSE